Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury
- PMID: 30674749
- PMCID: PMC6375819
- DOI: 10.2176/nmc.oa.2018-0254
Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury
Abstract
d-dimer is a potential biomarker for the detection of traumatic brain injury (TBI). However, the mechanisms that trigger elevation of d-dimer in TBI remain unclear. The purpose of this study was to evaluate the reliability of d-dimer in blood as a biomarker for TBI and to determine the mechanisms involved in regulating its blood levels. Nine patients with moderate to severe isolated TBI (Glasgow Coma Scale [GCS] score 7-13) were admitted to our hospital from May 2013 to June 2014. Blood samples were collected from systemic arteries on arrival and at 1, 3, 5, and 7 days after injury. Blood levels of neuron specific enolase (NSE), d-dimer, and soluble tissue factor (sTF) were measured. NSE (33.4 ng/ml: normal <12.0 ng/ml) and d-dimer (56.1 μg/ml: normal <1.0 μg/ml) were elevated at admission and declined on day 1 after injury. At admission, there were significant correlations of d-dimer levels with NSE (R = 0.727, P = 0.026) and sTF (R = 0.803, P = 0.009) levels. The blood level of d-dimer accurately reflects the degree of brain tissue damage indicated by NSE levels. Our data suggest that release of sTF induced by brain tissue damage may activate the coagulation cascade, leading to elevation of d-dimer.
Keywords: D-dimer; biomarker; neuron specific enolase; tissue factor; traumatic brain injury.
Conflict of interest statement
All authors have no conflicts of interest.
Figures



Similar articles
-
Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.World Neurosurg. 2018 Oct;118:e534-e542. doi: 10.1016/j.wneu.2018.06.234. Epub 2018 Jul 6. World Neurosurg. 2018. PMID: 30257306
-
Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury.J Neurotrauma. 2016 Apr 1;33(7):688-95. doi: 10.1089/neu.2015.4039. Epub 2015 Nov 20. J Neurotrauma. 2016. PMID: 26414158
-
Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.J Clin Pharmacol. 2018 Jan;58(1):42-47. doi: 10.1002/jcph.980. Epub 2017 Jul 19. J Clin Pharmacol. 2018. PMID: 28724200 Clinical Trial.
-
Serial measurement of S100B and NSE in pediatric traumatic brain injury.Childs Nerv Syst. 2019 Feb;35(2):343-348. doi: 10.1007/s00381-018-3955-y. Epub 2018 Aug 31. Childs Nerv Syst. 2019. PMID: 30171330
-
Prognostic role of D-dimer level upon admission in patients with traumatic brain injury.Medicine (Baltimore). 2018 Aug;97(31):e11774. doi: 10.1097/MD.0000000000011774. Medicine (Baltimore). 2018. PMID: 30075606 Free PMC article. Review.
Cited by
-
Plasma D-dimer levels are a biomarker for in-hospital complications and long-term mortality in patients with traumatic brain injury.Front Mol Neurosci. 2023 Oct 27;16:1276726. doi: 10.3389/fnmol.2023.1276726. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37965038 Free PMC article.
-
Association Between High-Level D-Dimer at Admission and Early Intubation in Patients With Moderate Traumatic Brain Injury.Neurotrauma Rep. 2023 Oct 25;4(1):715-723. doi: 10.1089/neur.2023.0068. eCollection 2023. Neurotrauma Rep. 2023. PMID: 37908323 Free PMC article.
-
Targeting Nrf2-Mediated Oxidative Stress Response in Traumatic Brain Injury: Therapeutic Perspectives of Phytochemicals.Oxid Med Cell Longev. 2022 Apr 4;2022:1015791. doi: 10.1155/2022/1015791. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35419162 Free PMC article. Review.
-
Serum D-dimer level as a predictor of neurological functional prognosis in cases of head injuries caused by road traffic accidents.BMC Emerg Med. 2022 Mar 26;22(1):51. doi: 10.1186/s12873-022-00613-9. BMC Emerg Med. 2022. PMID: 35346049 Free PMC article.
-
A metabolomic and proteomic analysis of pathologic hypercoagulability in traumatic brain injury patients after dura violation.J Trauma Acute Care Surg. 2023 Dec 1;95(6):925-934. doi: 10.1097/TA.0000000000004019. Epub 2023 Jul 5. J Trauma Acute Care Surg. 2023. PMID: 37405823 Free PMC article.
References
-
- Meizoso JP, Valle EJ, Allen CJ, et al. : Decreased mortality after prehospital interventions in severely injured trauma patients. J Trauma Acute Care Surg 79: 227–231, 2015 - PubMed
-
- Olivecrona Z, Bobinski L, Koskinen LO: Association of ICP, CPP, CT findings and S-100B and NSE in severe traumatic head injury. Prognostic value of the biomarkers. Brain Inj 29: 446–454, 2015 - PubMed
-
- Rodríguez-Rodríguez A, Egea-Guerrero JJ, Gordillo-Escobar E, et al. : S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury. Neurol Res 38: 130–137, 2016 - PubMed